Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum

European Journal of Pharmacology

Volumn 729, Issue 1, 2014, Pages 86-93

  Higashino, Kosuke ^a   Ago, Yukio ^a   Umehara, Masato ^a   Kita, Yuki ^a   Fujita, Kazumi ^a   Takuma, Kazuhiro ^a   Matsuda, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Desipramine; Dopamine; Mouse; Noradrenaline; Venlafaxine

Indexed keywords

DESIPRAMINE; DOPAMINE; NORADRENALIN; PROTEIN C FOS; SEROTONIN; VENLAFAXINE; BIOGENIC AMINE; CYCLOHEXANOL DERIVATIVE;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG EFFECT; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; MOLECULAR DYNAMICS; MOUSE; NEUROTRANSMISSION; NONHUMAN; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; ANIMAL; DRUG EFFECTS; EXTRACELLULAR FLUID; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM;

ANIMALS; BIOGENIC MONOAMINES; CORPUS STRIATUM; CYCLOHEXANOLS; DESIPRAMINE; EXTRACELLULAR FLUID; MALE; MICE; MICE, INBRED ICR; PREFRONTAL CORTEX;

EID: 84895135001     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.02.012     Document Type: Article

References (33)

1. Y. Ago, S. Nakamura, N. Kajita, M. Uda, H. Hashimoto, A. Baba, and T. Matsuda Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice Synapse 61 2007 757 763 (Pubitemid 47122748)
2. 1 receptor activation Psychopharmacology 217 2011 377 386
3. F.P. Bymaster, L.J. Dreshfield-Ahmad, P.G. Threlkeld, J.L. Shaw, L. Thompson, D.L. Nelson, S.K. Hemrick-Luecke, and D.T. Wong Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors Neuropsychopharmacology 25 2001 871 880 (Pubitemid 34031892)
4. E. Carboni, G.L. Tanda, R. Frau, and G. Di Chiara Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals J. Neurochem. 55 1990 1067 1070
5. 1A receptor antagonism Neuropharmacology 38 1999 1153 1163 (Pubitemid 29292404)
6. D.J.P. David, M. Bourin, G. Jego, C. Przybylski, P. Jolliet, and A.M. Gardier Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice Br. J. Pharmacol. 140 2003 1128 1136 (Pubitemid 37475979)
7. R.L. Findling, L.L. Greenhill, N.K. McNamara, C.A. Demeter, L.A. Kotler, M.A. O'Riordan, C. Myers, and M.D. Reed Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder J. Child Adolesc. Psychopharmacol. 17 2007 433 445 (Pubitemid 47417772)
8. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates. 1997 Academic Press, Inc. San Diego
9. 3H]-tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites Neurosci. Lett. 157 1993 203 206 (Pubitemid 23245529)
10. J. Grenhoff, and T.H. Svensson Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area Eur. J. Pharmacol. 233 1993 79 84 (Pubitemid 23091746)
11. E. Gur, E. Dremencov, B. Lere, and M.E. Newman Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo Eur. J. Pharmacol. 372 1999 17 24 (Pubitemid 29229859)
12. L. Hechtman, and B. Greenfield Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome Paediatr. Drugs 5 2003 787 794 (Pubitemid 38030604)
13. 1 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency Neuropharmacology 75 2013 53 61
14. T. Kihara, and M. Ikeda Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex J. Pharmacol. Exp. Ther. 272 1995 177 183
15. Y. Kitaichi, T. Inoue, T. Izumi, S. Nakagawa, A. Kato, and T. Koyama Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats Eur. J. Pharmacol. 520 2005 37 42 (Pubitemid 41375809)
16. S. Koch, S.K. Hemrick-Luecke, L.K. Thompson, D.C. Evans, P.G. Threlkeld, D.L. Nelson, K.W. Perry, and F.P. Bymaster Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats Neuropharmacology 45 2003 935 944 (Pubitemid 37297919)
17. K. Koda, Y. Ago, Y. Cong, Y. Kita, K. Takuma, and T. Matsuda Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice J. Neurochem. 114 2010 259 270
18. L. Linnèr, H. Endersz, D. Öhman, F. Bengtsson, M. Schalling, and T. Svensson Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex J. Pharmacol. Exp. Ther. 297 2001 540 546 (Pubitemid 32377983)
19. J. Mahmoudi-Gharaei, N. Dodangi, M. Tehrani-Doost, and T. Faghihi Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study Hum. Psychopharmacol. 26 2011 155 160
20. M.J. Millan, A. Gobert, F. Lejeune, A. Newman-Tancredi, J.M. Rivet, A. Auclair, and J.L. Peglion S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine J. Pharmacol. Exp. Ther. 298 2001 565 580 (Pubitemid 32673407)
21. National Research Council Guide for the Care and Use of Laboratory Animals. 1996 National Academy Press Washington, DC
22. R.L. Olvera, S.R. Pliszka, J. Luh, and R. Tatum An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents J. Child Adolesc. Psychopharmacol. 6 1996 241 250
23. G. Sacchetti, M. Bernini, A. Bianchetti, S. Parini, R.W. Invernizzi, and R. Samanin Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain Br. J. Pharmacol. 128 1999 1332 1338
24. S.R. Sesack, V.A. Hawrylak, C. Matus, M.A. Guido, and A.I. Levey Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter J. Neurosci. 18 1998 2697 2708 (Pubitemid 28141815)
25. W.X. Shi, C.L. Pun, X.X. Zhang, M.D. Jones, and B.S. Bunney Dual effects of d-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors J. Neurosci. 20 2000 3504 3511 (Pubitemid 30263765)
26. 3H]GBR 12935 as markers of dopamine innervation density in brain Synapse 25 1997 163 175 (Pubitemid 27121227)
27. G. Tanda, R. Frau, and G. Di Chiara Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex Psychopharmacology 127 1996 83 87 (Pubitemid 26298003)
28. G. Tanda, F.E. Pontieri, R. Frau, and G. Di Chiara Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine Eur. J. Neurosci. 9 1997 2077 2085 (Pubitemid 27485240)
29. M. Umehara, Y. Ago, K. Fujita, N. Hiramatsu, K. Takuma, and T. Matsuda Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats Eur. J. Pharmacol. 702 2013 250 257
30. 2-adrenoceptor activation Behav. Pharmacol. 24 2013 328 331
31. B. Vitiello Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder J. Child Adolesc. Psychopharmacol. 11 2001 25 34 (Pubitemid 32295180)
32. B.K. Yamamoto, and S. Novotney Regulation of extracellular dopamine by the norepinephrine transporter J. Neurochem. 71 1998 274 280 (Pubitemid 28292559)
33. A.R. Zarinara, M.R. Mohammadi, N. Hazrati, M. Tabrizi, S.A. Rezazadeh, F. Rezaie, and S. Akhondzadeh Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial Hum. Psychopharmacol. 25 2010 530 535